XII INTERNATIONAL WORKSHOP OF LOWER GENITAL TRACT … · LOWER GENITAL TRACT PATHOLOGY HPV diseases...
Transcript of XII INTERNATIONAL WORKSHOP OF LOWER GENITAL TRACT … · LOWER GENITAL TRACT PATHOLOGY HPV diseases...
XII INTERNATIONALWORKSHOP OFLOWER GENITALTRACT PATHOLOGY
HPV diseases and cervical cancer:taking stock of the present andplanning for the future.
Rome 5-7 March 2015Course DirectorsA. Frega, ItalyC. Gentili, ItalyP. Davies, Belgium
ORGANIZING SECRETARIATTriumph Italy S.r.l.Via Lucilio 60 - 00136 RomePhone: +39 06 35530 382Fax: +39 06 35530 [email protected]
Provider n. 712
Triumph ECM S.r.l.Via Lucilio, 60 - 00136 Rome
Ecm
Patronages Thursday 5 March
European Cervical Cancer Association
07:45 - 08:15 REGISTRATION
11:00 - 11:30 BREAK BREAK
13:00 - 14:30 LUNCH LUNCH
HPV disease of the HPV disease of the lower genital tract for lower genital tract
gynaecologists. for pathologists. First part First part
16:25 - 16:45 BREAK BREAK
ROOM A ROOM B
08:15 - 08:30 Welcome
08:30 - 09:00 HPV infection and cervical cancer
Cervical screening around 09:00 - 11:00 the world. Current status
and key challenges
Free communications
11:30 - 13:00 Challenges in Freecervical screening communications
14:30 - 16:25 Vaccination. Molecular tests in Part one the cytopathology lab
17:40 - 18:35 Challenging situations New issues 17:55 - 18:35 in colposcopy in cytophology
16:45 - 17:40 New frontiers in 16:45 - 17:55 colposcopy Liquid-based cytology
18:35 - 18:53 Twitter session Twitter sessionN
on-E
CM
Ses
sion
sEC
M C
ours
es3
With the Patronage of Italian Health Ministry
Saturday 7 March
ECM
Cou
rses
Non
-EC
M S
essi
ons
10:30 - 10:45 BREAK BREAK
HPV disease of the HPV disease of the lower genital tract for lower genital tract
gynaecologists. for pathologists. Third part Third part
ROOM A ROOM B
08:30 - 10:00 Atelier de travail Atelier de travail
10:00 - 10:30 Issues in clinic Focus on glandular lesions
12:00 - 12:45 Awards and conclusions
13:15 - 13:30 Closing ceremony
12:45 - 13:15 HPV disease: conclusions in twitter style
Friday 6 March
Non
-EC
M S
essi
ons
ECM
Cou
rses
10:00 - 10:30 BREAK BREAK
13:00 - 14:15 LUNCH LUNCH
HPV disease of the HPV disease of the lower genital tract for lower genital tract
gynaecologists. for pathologists. Second part Second part
ROOM A ROOM B
08:30 - 10:00 Clinical and pathology perspectives.
The actors speak. Part one
10:30 - 13:00 Clinical and pathology perspectives.
The actors speak. Part two
15:15 - 16:15 Management of CIN Pap-smear: never say never again
16:15 - 16:45 BREAK BREAK
Freecommunications
Freecommunications
11:45 - 12:00 ECM TEST ECM TEST
16:45 - 17:15 Issues in colposcopy Diagnosis in 16:45 - 17:45 cytopathology
17:15 - 18:3017:45 - 18:30 Multifocal diseases Legal questions
18:30 - 18:54 Twitter session Twitter session
10:45 - 11:45 Training in Training in colposcopy cytopathology
14:15 - 15:15 Vaccination. Classifications and Part two quality control in
cervical cytopathology
54
Thursday 5 March Thursday 5 MarchROOM A
08:15-08:30 WELCOMEA. Frega, C. Gentili
PLENARY SESSION
08:30-09:00 HPV INFECTION AND CERVICAL CANCERA. Frega, C. Gentili
08:30-08:45 The natural history of HPV infection: “What’s happening, brother?”M.T. Goodman
08:45-09:00 What do the natural history studies tell us about the mechanisms of progression vs regression and does this help clinical decision-making? B. Moscicki
09:00-11:00 CERVICAL SCREENING AROUND THE WORLD. CURRENT STATUS AND KEY CHALLENGESP. Davies, P. Giorgi Rossi
Cervical screening outside of Europe09:00-09:15 North America
R. Nayar09:15-09:30 South America
S. Tatti09:30-09:45 Asia
R. Sankaranarayanan09:45-10:00 Australasia
M. Saville
Cervical screening in Europe and the Caucasus10:00-10:20 Western Europe
H. Sancho-Garnier10:20-10:40 Eastern Europe
D. Valuta10:40-11:00 The Caucasus
T. Khomasuridze
11:00-11:30 BREAK
11:30-13:00 CHALLENGES IN CERVICAL SCREENINGL. Mariani, S. Tatti
11:30-11:45 Encouraging countries to move from opportunistic to organised screeningP. Davies
11:45-12:00 The introduction of HPV testing for primary screening. Feedback fromthe first organised programmes N. Van der Veen
12:00-12:15 Can self-sampling improve screening efficacy among populations with low-screening attendance? H. Sancho-Garnier 76
12:15-12:30 Screening vaccinated populations. As disease rates decline, when willscreening cause more harm than good? P. Nieminen
12:30-12:45 HPV RNA testing: can it improve the screening algorithm? K.U. Petry
12:45-13:00 DISCUSSION
13:00-14:30 LUNCH
ROOM A
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR GYNAECOLOGISTS. FIRST PART
14:30-16:25 VACCINATION. PART ONEA. Lukic, J. Paavonen
HPV vaccination around the world. The programmes, the coverage and the challenges
14:30-14:42 Europe and the Caucasus D. Valuta
14:42-14:54 North America R. Nayar
14:54-15:06 South America S. Tatti
15:06-15:18 Asia R. Sankaranarayanan
15:18-15:30 Australasia M. Saville
15:30-15:45 Planning a successful HPV vaccination launch: the key elements for successJ. Dillner
15:45-16:00 HPV vaccination implementation case study: the Dutch experienceM. Conyn-van Spaendonck
16:00-16:15 Vaccination: so how long does the protection really last?J. Dillner
16:15-16:25 DISCUSSION
16:25-16:45 BREAK
16:45-17:40 NEW FRONTIERS IN COLPOSCOPYK.U. Petry, F. Sesti
16:45-17:00 Colposcopy and HPV primary screening: clinical considerations P. Walker
17:00-17:15 Colposcopy in vaccinated populations: how to maintain performanceas disease rates decline J. Paavonen
17:15-17:30 The use of HPV-related biomarkers in different clinical applications M. Kyrgiou
17:30-17:40 DISCUSSION
Thursday 5 March09:40-11:00 MOLECULAR AND MORPHOLOGIST DIAGNOSIS
M.R. Giovagnoli, O. Nappi
09:40-09:50 P16INK4a/ki-67 detection in ASC-US and ASC-H cytology with HR-HPV DNA positive test and in corresponding histological sample:preliminary dataT. Addati, R. Nenna, D. Di Clemete, V. Losito, L. Vurchio, A. De Lucia,G. Elicio, P. Miscioscia, A. Belsanti, C.D. Inchingolo
09:50-10:00 Cervical Glandular Neoplasia and its look-a-like S. Rahimi, S. Kenward, I. Akaev, S. Votano
10:00-10:10 Incidence of HR HPV and histological alterations in Pap-test with ASC-USA. Berjawi Charour, N. Prats Montejano, G. Valdelvira Riego, M. Alsina Hipólito, Echavarría Ramos María del Carmen, E. Rodero Salgueiro
10:10-10:20 p16/Ki67 dual immunocytochemical staining implementation in threecytopathology laboratories participating in Slovenian cervical cancerscreening program ZORA V. Kloboves Prevodnik, U. Ivanuš, A. Repše Fokter, S. Hutter Celik, S. Jezeršek, U. Klopcic, Ž. Pohar Marinšek, K. Gornik Kramberger, N. Nolde, S. Uhan Kastelic, J. Zalar, M. Lešnjak, M. Fras, N. Irgel, B. Jelen, B. Antolovic, P. Pernat, L. Salobir, K. Seher Ana, N. Štiglic Toš, M. Primic Žakelj, M. Marcec, M. Pakiž, T. Kodric, U. Salobir Gajšek, J. Koren, I. Takac, M. Florjancic, T. Jerman
10:20-10:30 Comparative evaluation of RNA and DNA approach for HPV diagnosisM. Piovan, A. Apolloni, T. Bartolotti, C. Lapucci
10:30-10:40 Novel flow cytometry-based assay for detection of E6/E7 mRNA in cervical and anal specimensM. Mira, J. Coleman, D. Schapfel
10:40-10:50 Validation of in-house liquid based medium for HPV detection with Hybrid Capture 2N. Nolde, S. Uhan Kastelic, V. Kloboves Prevodnik, Ž. Pohar Marinšek,U. Ivanuš, M. Primic-Žakelj, M. Marcec, M. Pakiž, T. Kodric,U. Salobir Gajšek, J. Koren, A. Repše Fokter, I. Takac, S. Šramek Zatler, R. Kavalar, B. Grcar Kuzmanov, M. Florjancic, T. Jerman Tine
10:50-11:00 Assessment of Pap-smear qualitySakonlaya Dussadee, Yanagihara Luckakul
11:00-11:30 BREAK
11:30-11:50 MOLECULAR AND MORPHOLOGIST DIAGNOSISS. Votano, A. Frega
11:30-11:40 Non Hodgkin Lymphoma some features on the Pap-smearC. Bosco, A. Chiarugi, S. Cuccato, P. Viacava
11:40-11:50 HPV-mRNA test and multiple intraepithelial neoplasias of the femalelower genital tractG.N. Milazzo, A. Catalano, D. French, D. Caserta
98
Thursday 5 March17:40-18:35 CHALLENGING SITUATIONS IN COLPOSCOPY
A. Biamonti, P. Walker
17:40-17:55 Colposcopy in pregnancy: balancing the risk of pregnancy loss againstcancer development S. Dexeus
17:55-18:10 Colposcopy in menopause: challenges and solutions K.U. Petry
18:10-18:25 Colposcopy: do we need more evidence-based training, standards andQA or just random biopsies? W. Prendiville
18:25-18:35 DISCUSSION
18:35-18:53 TWITTER SESSIONF. Sesti, A. Lukic
18:35-18:41 Vaccination. Part oneJ. Dillner
18:41-18:47 New frontiers in colposcopyK.U. Petry
18:47-18:53 Challenging situations in colposcopyP. Walker
ROOM B
FREE COMMUNICATIONS
08:30-09:40 CERVICAL CANCER AND HPVD. French, A. Venuti
08:30-08:40 Autophagy is down-regulated by the E5 protein of human papillomavirus 16M. Nanni, F. Belleudi, S. Raffa, M.R. Torrisi
08:40-08:50 Epithelial target cell and the development of cervical disease - currentthinking and observationsR. Olaf, R. Sigrid
08:50-09:00 MicroRNA 551-b expression profile in cervical intraepithelial lesions M. Di Properzio, E. Carico, R. Mancini, C. De Vitis, S. Giglio, A. Noto, M.R. Giovagnoli, M. Moscarini, D. Caserta, A. Lukic
09:00-09:10 HPV16 E5 as target of immunotherapy F. Paolinii, M. Nazario Cordeiro, R. de Cássia Pereira de Lima, G. Curzio, A.C. de Freitas, A. Venuti
09:10-09:20 Human Papilloma Virus infection and his correlation with feminal parametersN. Grieco, M.A. Di Filippo, T. Notari, G. D’Aniello, S. Ronsini
09:20-09:30 The sumo conjugating enzyme ubc9 as a biomarker for cervical HPVinfectionsC. Casadio, D. Mattoscio, M. Fumagalli, M. Sideri, S. Chiocca
09:30-09:40 New prospect in HPV infection therapy P. Eid
Thursday 5 March Thursday 5 March15:00-15:15 HPV typing: do we know enough to base clinical decisions on HPV type
(… or would we treat a woman with HPV 16 differently from a womanwith HPV 33)? K.U. Petry
15:15-15:30 HPV E5 oncoprotein: possible role in L-SIL progression A. Venuti
15:30-15:45 Molecular bio-banking: a resource for research L. Dillner
15:45-16:00 What has changed in cytopathologist's report? M. Desai
16:00-16:25 DISCUSSION
16:25-16:45 BREAK
16:45-17:55 LIQUID-BASED CYTOLOGYC. Bergeron, G. Negri
16:45-17:15 The traditional Pap-test vs LBC. Two advocates present their cases L. Di Bonito, R. Nayar
17:15-17:30 LBC: a comparison of the systems M. Desai
17:30-17:45 Automation: can we afford it in these times of austerity?M. Saville
17:45-17:55 DISCUSSION
17:55-18:35 NEW ISSUES IN CYTOPATHOLOGYM. Benevolo, M. Desai
17:55-18:05 The Bethesda 2014 update: what's new? R. Nayar
18:05-18:20 Cytology and HPV testing in the prevention of anal cancer T.M. Darragh
18:20-18:35 DISCUSSION
18:35-18:53 TWITTER SESSIONL. Di Bonito
18:35-18:41 Molecular tests in the cytopathology labL. Dillner
18:41-18:47 LBCG. Negri
18:47-18:53 New issues in cytopathologyM. Saville
1110
11:50-12:40 EPIDEMIOLOGY, SCREENING AND PROGNOSTIC FACTORSG. Petricone, M. Benevolo
11:50-12:00 HPV multple infections, viral load and integration status: prognostic factors in secondary screening of cervical cancer L. Bianchi, S. Donati, Z. Napoli, M. Donati, A. Cafissi, M. Niccolai, R. Lari
12:00-12:10 Primary HPV test in cervical cancer screening in local health unit of Latina (Italy)C. Chiapetta, E. Lendaro, J. Cacciotti, G. Migliore, P. Bellaridini, N. Porta, V. Petrozza, C. Della Rocca, C. Di Cristofano
12:10-12:20 The 16, 18 and 45 HPV infection triage in primary HR-HPV test screening program in local health unit of Latina (Italy)C. Chiappetta, E. Lendaro, J. Cacciotti, R. Zaralli, C. Puggioni, G. Migliore, V. Petrozza, C. Della Rocca, C. Di Cristofano
12:20-12:30 Cervical cancer screening and cervical excisional treatment among women aged below 25 years between 2007 and 2013 in France I. Heard, C. Chaignot, G. Maura, A. Weill, F. Alla, P. Ricordeau
12:30-12:40 Cervical CancerÖ. Nöoeighöowa
12:40-13:10 EDUCATION AND AWARENESSA. Lukic, P. Scirpa
12:40-12:50 Perception about cervical cancer prevention of daughters in Korean mothersK.Hae Won
12:50-13:00 Primary prevention of HPV infection for adolescents L. Dubravko
13:00-13:10 Mediation effects of fear of cancer recurrence on cancer distress andquality of life in cervical cancer patientsT. Shiow-Luan, H. Chia-Ching
13:10-14:30 LUNCH
ROOM B
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR PATHOLOGISTS. FIRST PART
14:30-16:25 MOLECULAR TESTS IN THE CYTOPATHOLOGY LABT.M. Darragh, D. French
14:30-14:45 Getting around in molecular testing jungle: what clinicians and pathologists should know to properly interpret the results L. Dillner
14:45-15:00 Molecular tests: which tests are ready for clinical use and what do they add to clinical algorithms? M. Kyrgiou
Friday 6 MarchROOM A
PLENARY SESSION
08:30-10:00 CLINICAL AND PATHOLOGY PERSPECTIVES. THE ACTORS SPEAK. PART ONEA. Biamonti, G.L. Taddei
Cervical cytology or the molecular model: which is the best way forward?
08:30-08:40 Clinical perspective P. Nieminen
08:40-08:50 Cytopathology perspective R. Nayar
08:50-09:00 OPEN DISCUSSION
ASC-US and AGC: can we get over this deadlock?09:00-09:10 Clinical perspective
P. Walker09:10-09:20 Cytopathology perspective
G. Negri09:20-09:30 OPEN DISCUSSION
CIN 2. Where are we now: do we treat it or not? 09:30-09:40 Clinical perspective
B. Moscicki09:40-09:50 Cytopathology perspective
T.M. Darragh09:50-10:00 OPEN DISCUSSION
10:00-10:30 BREAK
10:30-13:00 CLINICAL AND PATHOLOGY PERSPECTIVES. THE ACTORS SPEAK. PART TWOA. Lukic, G.L.Taddei
Persistently HPV positive but cytology and colposcopy negative: what are the clinical recommendations?
10:30-10:40 Cytopathology perspective M. Saville
10:40-10:50 Clinical perspective W. Prendiville
10:50-11:00 OPEN DISCUSSION
HSIL but clinically normal: who is wrong? 11:00-11:10 Cytopathology perspective
M. Desai11:10-11:20 Clinical perspective
K.U. Petry11:20-11:30 OPEN DISCUSSION
Combining molecular tests: can this improve clinical decisions?11:30-11:40 Cytopathology perspective
C. Bergeron
Friday 6 March
1312
11:40-11:50 Clinical perspective M. Kyrgiou
11:50-12:00 OPEN DISCUSSION
What can and can’t the pathologist say to clinician and the clinician to the pathologist?
12:00-12:10 Cytopathology perspective L. Di Bonito
12:10-12:20 Clinical perspective S. Dexeus
12:20-12:30 OPEN DISCUSSION
Revised terminology for cervical histopathology and its implicationsfor management of HSIL
12:30-12:40 Pathology perspective T.M. Darragh
12:40-12:50 Clinical perspective S. Tatti
12:50-13:00 OPEN DISCUSSION
13:00-14:15 LUNCH
ROOM A
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR GYNAECOLOGISTS. SECOND PART
14:15-15:15 VACCINATION. PART TWOR. De Vincenzo, E. Siegler
14:15-14:30 HPV vaccination: three doses, two doses or just one? R. Sankaranarayanan
14:30-14:45 What is the most cost-effective target population? Girls? Boys? Women? Men? Everybody? J. Dillner
14:45-15:00 New developments in HPV vaccination: what do we know about the nonavalent vaccine? J. Paavonen
15:00-15:15 DISCUSSION
15:15-16:15 MANAGEMENT OF CINB. Moscicki, P. Scirpa
15:15-15:30 Clinical guidelines vs. clinical judgement: where do you draw the line?P. Walker
15:30-15:45 Treating CIN during pregnancy: key criteria and treatment options E. Siegler
15:45-16:00 Treating recurrent CIN while preserving fertility in the nulliparous younger womanM. Kyrgiou
16:00-16:15 DISCUSSION
Friday 6 March Friday 6 March09:00-09:10 Measurement of Quality of Colposcopy within cervical screening in
Europe-Quality Assurance of Colposcopy Italian Network (QuACINet)C. Carriero, S. Leeson, F. Boselli
09:10-09:20 Fertility and early pregnancy outcomes after treatment for cervical intra-epithelial neoplasia: a systematic review and meta-analysis of the literatureM. Kyrgiou, A. Mitra, M. Arbyn, S.M. Stasinou, P. Martin-Hirsch, P. Bennett, E. Paraskevadis
09:20-09:30 Management of patients with cytological low-grade or borderline abnormalities: how powerful is a negative colposcopy? C. Ricci, M. Martin, K. Neenan, W. Prendiville
09:30-09:40 A case of AIS in pregnancy M.T. Evangelista, M.R. Primieri, C. Ricci, I.N. Trivellizzi, C. Conte,R. De Vincenzo, G. Scambia, P. Scirpa
09:40-09:50 A case of pregnancy after treatment for IA2 cervical cancer M.T. Evangelista, M.R. Primieri, C. Ricci, I.N. Trivellizzi, C. Conte,R. De Vincenzo, G. Scambia, P. Scirpa
10:00-10:30 BREAK
10:30-10:50 HPV TESTING AND VACCINATIOND. French, A. Biamonti
10:30-10:40 Cyto-colposcopic follow-up of an HPV vaccinated cohort of women inItaly: what should we expect in real life? R. De Vincenzo, C. Conte, N.I. Trivellizzi, C. Ricci, M.T. Evangelista, M.R. Primieri, P. Scirpa, G. Scambia
10:40-10:50 Speranza study: preliminary results of HPV vaccination after loop electrosurgical excision procedure for cervical intraepithelial neoplasia A. Ghelardi
10:50-12:00 CERVICAL CANCER PREVENTION IN LOW-RESOURCES SETTINGSR. Sankaranarayanan, A. Venuti
10:50-11:00 Prevalence of human papilloma virus infection and cervical pre cancerlesions among female sex workers in Mumbai, IndiaP. Sharmila, M. Gauravi, S. Surendra
11:00-11:10 Development of HPV PCR assay in menstrual pad for rural Indian Women: Pilot study data. Experience while standardizing method P. Vrushali, B. Atul, M. Perveen, L. Manoj, M. Amita, P. NS, P. Palllavi, D. Rajesh, V. Ashok
11:10-11:20 Cervical cancer screening in Madagascar: usability of mobile telemedicine for detection of precancerous lesions from smartphonephotosR. Catarino, D. Ricard-Gauthier, J.C. Matute, U. Meyer-Hamme, M. Undurraga, S. Scariengella, J. Jinoro, P. Vassilakos, P. Petignat
11:30-11:40 Comparative evaluation of Hybrid Capture 2 and cytology as triage tests among VIA/ VILI screen positive womenM. Gauravi, S. Surendra, K. Sheetal
1514
16:15-16:45 BREAK
16:45-17:15 ISSUES IN COLPOSCOPYM. Kyrgiou, C. Zanardi
16:45-17:00 Cervical cancer after CIN treatment: wrong diagnosis, inadequate therapy or just bad luck? W. Prendiville
17:00-17:15 What are the medical-legal risks in colposcopy and who are the bestmedical defence lawyers in each country? P. Walker
17:15-18:30 MULTIFOCAL DISEASESA. Biamonti, S. Dexeus
17:15-17:30 Multifocal lesions: how and why do they occur?M.T. Goodman
17:30-17:45 VIN HPV relatedL. Micheletti
17:45-18:15 Anal intraepithelial lesions in women with HPV-related disease S. Tatti
18:15-18:30 DISCUSSION
18:30-18:54 TWITTER SESSIONM. Kyrgiou, L. Mariani
18:30-18:36 HPV vaccination. Part twoL. Dillner
18:36-18:42 Management of CINE. Siegler
18:42-18:48 Issues in colposcopyS. Dexeus
18:48-18:54 Multifocal diseasesM.T. Goodman
ROOM BFREE COMMUNICATIONS
08:30-09:50 COLPOSCOPYF. Sesti, R. De Vincenzo
08:30-08:40 Chemotherapy in pregnant women with cervical cancer: a single institution experience C. Ricci, I.N.Trivellizzi, C. Conte, G. Scambia, R. De Vincenzo
08:40-08:50 HPV-positive patients with the CIN relapse -further procedure and treatment R. Živadinovic, A. Petric, D. Krtinic
08:50-09:00 “See and treat” strategy for HSIL: correlation between colposcopy and histopathologyC. Dragosloveanu, R. Vladareanu
Friday 6 March Friday 6 March
1716
15:45-16:00 What molecular biology cannot provide G. Negri
16:00-16:15 DISCUSSION
16:15-16:45 BREAK
16:45-17:45 DIAGNOSIS IN CYTOPATHOLOGYL. Di Bonito, T.M. Darragh
16:45-17:00 Cytology accuracy: can more training compensate for time constraints? M. Saville
17:00-17:15 Cytology during pregnancy: does it need to be interpreted differentlydepending on the stage of pregnancy? M. Desai
17:15-17:30 Cytology in menopause: challenge for the pathologist G. Negri
17:30-17:45 DISCUSSION
17:45-18:30 LEGAL QUESTIONSG. Negri, M. Saville
17:45-18:00 Over-diagnosis in cytopathology: is the histology the gold standard? T.M. Darragh
18:00-18:15 Legal questions in the lab with the new molecular algorithms R. Nayar
18:15-18:30 DISCUSSION
18:30-18:54 TWITTER SESSIONM. Benevolo, T.M. Darragh
18:30-18:36 Classifications and quality control in cervical cytopathologyC. Bergeron
18:36-18:42 Pap-smear: never say never againG. Negri
18:42-18:48 Diagnosis in cytopathologyL. Di Bonito
18:48-18:54 Legal issues for the cytopathologistM. Desai
11:40-11:50 Population based screenings for cervical cancer: cost effective approach in low resource setting using high end methodology in triaging algorithm and genomic integrations N. Manu, A. Maninder
11:50-12:00 Chemopreventive effects of curcumin on cervical cancers and precancerous cellsS. Dusadee, T. Pirath, P. Auragun, C. Saengsoon
12:00-12:40 MISCELLANEOUSM.T. Goodman, R. Senatori
12:00-12:10 Characterization of the vaginal microbiome in women with cervical intraepithelial neoplasia A. Mitra, D. MacIntyre, L. Yun, A. Smith, J. Marchesi, E. Holmes, J. Nicholson, P. Bennett, M. Kyrgiou
12:10-12:20 Impact of Sexually Transmitted Diseases in pregnancy: knowledge ofpregnant women C. Caixeta
12:20-12:30 Rare genitourinary anomalies M. Fahmy
12:30-12:40 Prevalence of co-infections with human papillomavirus and mycoplasma/ureaplasma species in women with abnormal cervical cytologyJi Yong Il
13:00-14:15 LUNCH
ROOM B
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR PATHOLOGISTS. SECOND PART
14:15-15:15 CLASSIFICATIONS AND QUALITY CONTROL IN CERVICAL CYTOPATHOLOGYG. Negri, M. Saville
14:15-14:35 Cervical cytology specimen adequacy: patient management guidelinesand optimizing specimen collection C. Bergeron
14:35-14:55 Quality control in cervical cytology: can we exploit the biomarkers? M. Desai
14:55-15:15 DISCUSSION
15:15-16:15 PAP-SMEAR: NEVER SAY NEVER AGAINR. Nayar, A. Venuti
15:15-15:30 Cervical cytology: can it survive in the era of HPV vaccination? C. Bergeron
15:30-15:45 Why East European countries should still devote resources to the Pap-smearP. Davies
Saturday 7 March Saturday 7 March
1918
ROOM A
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR GYNAECOLOGISTS. THIRD PART
08:30-10:00 ATELIER DE TRAVAILG. Petricone, P. Stentella
Video interactive session on colposcopy coordinated by Walter PrendivilleM. Barbero, A. Biamonti, S. Dexeus, K.U.Petry, S. Tatti, P. Nieminen
10:00-10:30 ISSUES IN CLINICC. Carriero, S. Votano
10:00-10:15 Challenge in menopause: improving diagnosis and treatment F.M. Primiero
10:15-10:30 HR HPV genotypes on spermatozoa from male partners of infertile couplesA. Perino
10:30-10:45 BREAK
10:45-11:45 TRAINING IN COLPOSCOPYF. Boselli, P. Inghirami
10:45-11:00 Minimal standards in colposcopy M. Peroni
11:00-11:15 How to audit your colposcopy practice P. Cristoforoni
11:15-11:30 The nurse colposcopist: salvation or heresy? W. Prendiville
11:30-11:45 DISCUSSION
11:45-12:00 ECM TEST
ROOM B
ECM COURSE: HPV DISEASE OF THE LOWER GENITAL TRACT FOR PATHOLOGISTS. THIRD PART
08:30-10:00 ATEILER DE TRAVAILM.R. Giovagnoli, G.F. Zannoni
Interactive slide seminarL. Di Bonito, G. Negri
10:00-10:30 FOCUS ON GLANDULAR LESIONSL. Di Bonito, G. Negri
10:00-10:15 Atypical glandular cells and its differential diagnosis from true lesionsM. Desai
10:15-10:30 Histological implication of Pap-smear classified as atypical glandular cellG.F. Zannoni
10:30-10:45 BREAK
10:45-11:45 TRAINING IN CYTOPATHOLOGYL. Di Bonito, G.Negri
10:45-11:00 The role of cytotechnician in the labC. Bosco
11:00-11:15 How can I update myself: courses, books, e-learning, DIY (do it yourself)…?M.R. Giovagnoli
11:15-11:30 How to audit my own practice M. Desai
11:30-11:45 DISCUSSION
11:45-12:00 ECM TEST
ROOM APLENARY SESSION
12:00-12:45 AWARDS AND CONCLUSIONSA. Frega, C. Gentili
12:00-12:30 PRESENTATION AND AWARDING OF THE THREE BEST COMMUNICATIONS
12:30-12:45 AWARDING OF THE THREE BEST SPEAKERS
12:45-13:15 HPV DISEASE. CONCLUSIONS IN TWITTER STYLER. Senatori, S. Votano
12:45-12:51 HPV infection and cervical cancer L. Mariani
12:51-12:57 Screening around the world P. Davies
12:57-13:03 HPV vaccination R. De Vincenzo
13:03-13:09 Colposcopy today P. Walker
13:09-13:15 Cytology: quo vadis? G. Negri
13:15-13:30 CLOSING CEREMONY
SpeakersB. Moscicki San Fransisco, U.S.
O. Nappi Naples, Italy
R. Nayar Evanston, U.S.
G. Negri Bolzano, Italy
P. Nieminen Helsinki, Finland
J. Paavonen Helsinki, Finland
A. Perino Palermo, Italy
M. Peroni Ascoli Piceno, Italy
G. Petricone Rome, Italy
K.U. Petry Wolsfburg, Germany
W. Prendiville Lyon, France
F.M. Primiero Rome, Italy
H. Sancho-Garnier Montpellier, France
R. Sankaranarayanan Lyon, France
M. Saville Victoria, Australia
P. Scirpa Rome, Italy
R. Senatori Rome, Italy
F. Sesti Rome, Italy
E. Siegler Haifa, Israel
P. Stentella Rome, Italy
G.L. Taddei Florence, Italy
S. Tatti Buenos Aires, Argentina
D. Valuta Chisinau, Moldova
N. Van der Veen Bilthoven, The Netherlands
A. Venuti Rome, Italy
S. Votano Rome, Italy
P. Walker London, UK
C. Zanardi Bologna, Italy
G.F. Zannoni Rome, Italy
SpeakersM. Barbero Asti, Italy
M. Benevolo Rome, Italy
C. Bergeron Paris, France
A. Biamonti Rome, Italy
C. Bosco Viareggio, Italy
F. Boselli Modena, Italy
C. Carriero Bari, Italy
M. Conyn-van Spaendonck Bilthoven, The Netherlands
P. Cristoforoni Genoa, Italy
T.M. Darragh San Francisco, U.S.
P. Davies Brussels, Belgium
R. De Vincenzo Rome, Italy
M. Desai Manchester, UK
S. Dexeus Barcelona, Spain
L. Di Bonito Trieste, Italy
J. Dillner Malmo, Sweden
L. Dillner Stockholm, Sweden
A. Frega Rome, Italy
D. French Rome, Italy
C. Gentili Carrara, Italy
P. Giorgi Rossi Rome, Italy
M.R. Giovagnoli Rome, Italy
M.T. Goodman Los Angeles, U.S.
P. Inghirami Rome, Italy
T. Khomasuridze Istanbul, Turkey
M. Kyrgiou London, UK
A. Lukic Rome, Italy
L. Mariani Rome, Italy
L. Micheletti Turin, Italy 2120
General InformationLOCAL ORGANIZING COMMITTEEAlberto Biamonti, ItalyRosa De Vincenzo, ItalyDeborah French, ItalyGiancarlo Petricone, ItalyPaolo Scirpa, ItalyFrancesco Sesti, ItalySergio Votano, Italy
SCIENTIFIC COMMITTEEChristine Bergeron, FranceMina Desai, UKJoakim Dillner, SwedenAnkica Lukic, ItalyBarbara Moscicki, U.S.K. Ulrich Petry, GermanyWalter Prendiville, FrancePatrick Walker, UK
General InformationCONGRESS VENUEErgife Palace HotelVia Aurelia, 61900165 - Rome
LANGUAGEThe official language of the Workshop is English. Simultaneous translation intoItalian will be provided.
ECM ACCREDITATIONDuring the Congress there will be two ECM Courses, one in Room A and one inRoom B. The two courses will be simultaneous and will last three days (2 af-ternoon Sessions and 1 morning Session each). To obtain the credits is neces-sary to attend only one course, follow the 100% of the training activity and toexceed the questions proposed by the follow-up test. The effective attendeeswill be verified by signature of the dedicated records at the time of entranceand exit. Partial and missing survey of participation to the convention works,will not allow ECM accreditation. ECM Test will be distributed by hostesses.Participants will duly have to fill them in, sign and return them to the Secreta-riat.The Course “HPV DISEASE OF THE LOWER GENITAL TRACT FOR GYNAECOLO-GISTS” has been accredited for 5,5 ECM credits (712-114514).The Course “HPV DISEASE OF THE LOWER GENITAL TRACT FOR PATHOLO-GISTS” has been accredited for 5,5 ECM credits (712-114550).
The specialities and disciplines able to apply for Italian ECM credits are:- Medico Chirurgo/Surgeon (Anatomia Patologica; Igiene, epidemiologia e sanità pub-
blica; Ginecologia e Ostetricia; Oncologia; Patologia clinica (laboratorio di analisi chi-mico-cliniche e microbiologia));
- Biologo/Biologist (Anatomia Patologica; Igiene, epidemiologia e sanità pubblica; Pa-tologia clinica (Laboratorio di analisi chimico-cliniche e microbiologia));
- Tecnici di laboratorio biomedico/ Biomedical laboratory technicians.National educational aim n. 1: Applicazione nella pratica quotidiana dei principi e delleprocedure dell'evidence based practice/Application in the daily practice of the principlesand procedures of the evidence based practice.
PARTICIPANTS RECRUITMENTOn the 18th of January 2011 the National ECM commission defined: Sanitary professionals can usedirect sponsorships by agencies till 50 ECM credits out of the 150 ECM credits to be acquired throu-ghout three years 2014/16 with the registration of the order of belongings.The credit certificate will be checked out by COGEAPS and orders, associations where the profes-sional is registered till the greater quote of 1/3.
ORGANIZING SECRETARIAT
Triumph Italy S.r.l.Via Lucilio 60 - 00136 RomePhone: +39 06 35530 382Fax: +39 06 35530 [email protected]
Provider n. 712
Triumph ECM S.r.l.Via Lucilio, 60 – 00136 Rome
Ecm
2322
Floor plan
EXHIBITION AREA
ALPRETEC 7
ARROW DIAGNOSTICS 15
CENTREL 11
CLINIC SERVICE 9
DIGI MEDICA 4
FARMA-DERMA 12
FARMITALIA 17
FUJIREBIO 19
GALBERT 8
GENETICLAB 6
GYNIUS 10
HOLOGIC 18
IDI 3
LIBRERIA STUDIUM 1
LJ PHARMA 16
PROGINE 2
QIAGEN 20
REF 14
SAKURA 13
TEGEA 9
VERDUCI EDITORE 5
Floor plan
2524
�����
����
�
SLIDE CENTREECNARTNE
egarots
RECEPTION DESK
ROOM B
CLOACKROOM
1 2
3
4
5 6
7 8 9 10 11 12 20
14
15
18 19 ROOM A 16
13
17
SponsorFor the unconditional educational support
Sponsor
2726